Brexit creeping closer – or?

In this column, lawyer Pernilla Norman, tries to sort out the different Brexit options.

Marie Gårdmark: New incentives for orphan products on its way

"Let’s hope that the learnings from development of new therapies for rare diseases will spill over to more common conditions, orphan products paving the wave fo...

Anna Törner: To kill your darlings

Hopes were high when Anna Törner and her colleague started a study on a dietary supplement that seemed unbelievably good. “Enthusiastically, we dreamed of excit...

Astra Zenecas Sverige-vd: ”Vi tror superstarkt på vår portfölj”

Det började med sommarjobb som operatör på Astras kemifabrik i Snäckviken. Över tre decennier och otaliga olika uppdrag senare är Södertäljesonen Per Alfredsson...

Ny kunskap om sällsynt grundämne

Forskare från Göteborgs universitet har lyckats skapa små mängder av världens mest sällsynta grundämne.

Brexit looking back and looking forward

More than 3 years have passed after the vote and there is still uncertainty around the outcome although the UK December 12 election set a clearer course towards...

Hello Angelica Loskog!

Life Science Sweden would like to know more about Angelica Loskog and interviews her about her life as a researcher.

Landets life science-strategi – var med och påverka den!

Det statliga life science-kontorets chef Jennie Nordborg vill veta vad de ska ha med i den nationella life science-strategin. Nu vill hon ha din åsikt!

TV: Spelifieringen ändrar beteenden

Beteenden och livsstil kan påverkas med mer lekfullhet. Life science-branschen fick lära sig mer om ämnet vid möte i Göteborg.

A world-class research village

Eight years ago, Medicon Village was set up in Lund. Since then, this hub for research, innovation and business has developed enormously, and today the life sci...

TV: Vårdutbildningar ska bli mer tekniska

Agneta Holmäng, professor och dekan vid Sahlgrenska Akademin, tänker föra in mer teknik i utbildningen av vårdpersonal.

TV: Mjukvaruföretag går in i USA

Svenskt företag med stödsytem för läkemedelsutveckling år in i USA. Detta är framgångsfaktorerna.

Pilots want to live too

New rules for diagnostic products, but who will certify them? “An extreme shortage area”

In less than two weeks, new and stricter EU rules will enter into force for thousands of products used in important diagnoses of, among other things, cancer and...

Pharma-on-Demand

Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...

The best wealth is Health

We are living in a world where wealth more and more is measured in being able to do the things you like and enjoy in life. As the wealth increases in terms of e...

TV: Astrazeneca väljer Sverige

Och vill se fler life science-grannar i Göteborg

Nano-antikropp från alpacka blockerade coronavirus

Ett fragment av en antikropp från en alpacka verkar kunna blockera det nya corona-viruset från att ta sig in i celler.

From spin-off to phase II

”The people there will basically become your new colleagues” – Carina Schmidt, former CEO of Athera, about working with different contractors.

Biden utser coronateam – hans rådgivare kritiserar Tegnell

USA:s nya president Joe Biden intar en helt ny hållning i bekämpningen av covid-19 än sin företrädare. Hans rådgivare Andy Slavitt kritiserade nyligen Anders Te...

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

Globalt uttalande

Pfizers globala uttalande efter patentgodkännande av Prevenar 13 i Indien.

Anna Törner: You won’t find this many Concorde projects anywhere else

"Suddenly Concorde projects seem reasonable in life science because it´s about life and death", writes Anna Törner in a column.

Before you choose a CRO

– We are a small company and it is very important for us to maintain our core competence within development of novel nanomaterials, Tove Sivik Sonne, Head of De...